By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab which could potentially end Aids, the Trump administration undercuts its own ...

As we mark World AIDS Day this week, it's time to pause and ask why HIV-AIDS remains one of Namibia's most stubborn health concerns.People are still getting the virus, with poverty driving unprotected ...

Pepfar has transformed HIV/AIDS prevention and treatment in Africa over two decades, but recent political disruptions and funding threats now put millions of lives and long-term progress at risk.

The first deliveries of lenacapavir to the African continent represent a turning point in the fight against HIV.

Around 1,000 doses of Gilead Sciences' HIV prevention drug, lenacapavir, were sent to Zambia and Eswatini under a U.S. initiative. However, South Africa, with the highest HIV burden, will not receive ...

The global public health community is raising significant concerns about recent Trump administration actions, including a funding freeze and stop-work order, as well as a large number of employees at ...

Zambia's HIV care is heavily reliant on PEPFAR, with 84% of funding from the US, crucial for achieving UNAIDS' "95-95-95" goals. The EMOD-HIV model predicts significant increases in HIV-related deaths ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...